# Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy

> **NCT01338025** · PHASE4 · TERMINATED · sponsor: **International Maternal Pediatric Adolescent AIDS Clinical Trials Group** · enrollment: 33 (actual)

## Conditions studied

- HIV Disease

## Interventions

- **DRUG:** HAART regimen
- **DRUG:** 3TC or FTC monotherapy

## Key facts

- **NCT ID:** NCT01338025
- **Lead sponsor:** International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Study was halted for lack of accrual
- **Last updated:** 2015-11-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01338025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01338025, "Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01338025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*